Alexion Pharma (Switzerland)
In research, Alexion Pharma (Switzerland) stands highest in Health Sciences (#6,677 of 11,982 worldwide) and Medicine (#8,183 of 10,443 worldwide), 2022–2025.
- World rank, 2022–2025
- #11,302 of 28,054 · #16,749 all time
- Rank in Switzerland
- #68 of 220
- Research works
- 687 ▲ 44% vs 2013–17
- Citations
- 7.7k 11.2 per fractional work
- Top-10% rate
- 14.2% record average 16.5%
- Open access
- 53% world 28%
What is Alexion Pharma (Switzerland) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #6,677 of 11,982 | 18.6% | 91 | #10259 | |
| MedicineField | #8,183 of 10,443 | 15.8% | 76 | #11578 |
Each strip is that field’s whole ranked pool, with the notch where Alexion Pharma (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 6.3×. Every wedge is a field page.
- Dentistry 6.3×
- Immunology and Microbiology 3.4×
- Veterinary 2.8×
- Nursing 2.2×
- Medicine 1.8×
- Economics, Econometrics and Finance 1.7×
- Agricultural and Biological Sciences 1.6×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Neuroscience 1.4×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Health Professions 1.0×
- Psychology 1.0×
- Arts and Humanities 0.8×
- Computer Science 0.6×
- Environmental Science 0.6×
- Business, Management and Accounting 0.6×
- Social Sciences 0.6×
- Chemistry 0.5×
- Engineering 0.4×
- Energy 0.4×
- Materials Science 0.3×
- Physics and Astronomy 0.3×
- Decision Sciences 0.2×
- Mathematics 0.2×
- Chemical Engineering 0.1×
Who are the top researchers at Alexion Pharma (Switzerland)?
Ranked on the composite score, Revista Completa and Mark Seymour lead among researchers whose main affiliation is Alexion Pharma (Switzerland).
- 1 Revista Completa Switzerland · #792,373 worldwide 0 citations · 15 works
- 2 Mark Seymour Switzerland · #1,114,911 worldwide 10 citations · 15 works
Which keywords describe research at Alexion Pharma (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Prognosis, Treatment, Quality of Life, Diagnosis, Autoantibodies, Clinical Trials and Ethical Issues.
- Virtual Screening
- Genome Engineering
- Quality
- Immune
- Inflammatory Diseases
- Regulatory Challenges
- Policy
- Innovation Policy
- Myasthenia Gravis
- Bioenergy
- Innate Immunity
- Regenerative Medicine
- Pathogenesis
- Obesity
- Neurological Disorders
- Genetics
- Clinical Trials
- Oxidative Stress
- Diagnosis
- Quality of Life
- Epidemiology
- Treatment
- Inflammation
- Prognosis
- Public Health
- Autoantibodies
- Immunotherapy
- Ethical Issues
- Cardiovascular Risk
- Weight Loss
- Neuromuscular Junction
- Legal Regulation
- Thymic Tumors
- Pharmacokinetics
- Microbiota
- Dietary Fiber
- Complement
- Monoclonal Antibodies
- Economic Evaluation
- RNA-Guided
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology18▲ 2.0×69 topics
- Quality of Life9▲ 2.8×24 topics
- Treatment9▲ 3.3×29 topics
- Diagnosis7▲ 3.5×22 topics
- Inflammation7▲ 1.54×37 topics
- Oxidative Stress6▲ 1.77×33 topics
- Prognosis6▲ 8.7×6 topics
- Clinical Trials6▲ 4.1×14 topics
- Public Health6▲ 1.76×21 topics
- Genetics5▲ 3.4×16 topics
- Autoantibodies5▲ 9.4×8 topics
- Neurological Disorders5▲ 3.9×11 topics
- Immunotherapy4▲ 2.8×7 topics
- Obesity4▲ 2.6×10 topics
- Ethical Issues4▲ 16×3 topics
- Pathogenesis4▲ 3.3×14 topics
- Cardiovascular Risk4▲ 5.4×8 topics
- Regenerative Medicine3▲ 6.0×5 topics
- Weight Loss3▲ 9.4×4 topics
- Innate Immunity3▲ 4.7×4 topics
- Neuromuscular Junction3▲ 36×2 topics
- Bioenergy3▲ 27×2 topics
- Legal Regulation3▲ 6.3×3 topics
- Myasthenia Gravis3▲ 73×1 topic
- Thymic Tumors3▲ 73×1 topic
- Innovation Policy3▲ 13×3 topics
- Pharmacokinetics3▲ 4.8×4 topics
- Policy3▲ 5.8×5 topics
- Microbiota3▲ 5.6×5 topics
- Regulatory Challenges3▲ 14×2 topics
- Dietary Fiber3▲ 11×2 topics
- Inflammatory Diseases2▲ 6.4×2 topics
- Complement2▲ 64×1 topic
- Immune2▲ 64×1 topic
- Monoclonal Antibodies2▲ 12×3 topics
- Quality2▲ 25×2 topics
- Economic Evaluation2▲ 8.3×2 topics
- Genome Engineering2▲ 15×1 topic
- RNA-Guided2▲ 15×1 topic
- Virtual Screening2▲ 11×1 topic
Which research topics does Alexion Pharma (Switzerland) publish most on?
By volume in 2022–2025: Myasthenia Gravis and Thymoma, Complement system in diseases, CRISPR and Genetic Engineering and Computational Drug Discovery Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Myasthenia Gravis and Thymoma Neurology 3 works
- 2 Complement system in diseases Immunology 2 works
- 3 CRISPR and Genetic Engineering Molecular Biology 2 works
- 4 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 6 Rabbits: Nutrition, Reproduction, Health Animal Science and Zoology 2 works
- 7 Anaerobic Digestion and Biogas Production Building and Construction 2 works
- 8 Biomedical Ethics and Regulation Physiology 2 works
- 9 Digital Transformation in Law General Economics, Econometrics and Finance 2 works
- 10 Bariatric Surgery and Outcomes Surgery 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alexion Pharma (Switzerland)'s research output changed?
Output in 2018–2022 was 44% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zurich
- ETH Zurich
- University of Zurich
- University Hospital of Zurich
- Board of the Swiss Federal Institutes of Technology
- ABB (Switzerland)
- University Children's Hospital Zurich
- Zurich University of Applied Sciences in Business Administration
- Institute for Biomedical Engineering
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.